Skip to content
DataLookout
Menu

NCT07436637

Guardant Shield Colorectal Cancer Screening

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Final enrollment: 2 participants, under 1% of the 500 planned
    • Enrollment closed, study ongoing
    • Site details revised
  2. Notable Eligibility criteria expanded, about 10 words
    • Site contact updated
  3. Notable Recruitment opened
    • Start date changed from estimate of Jun 30, 2026 to Jul 22, 2026
    • Site details revised
    v5
  4. Notable Start date: May 30, 2026 to Jun 30, 2026v4
  5. Notable Start date: Apr 1, 2026 to May 30, 2026v3
  6. Notable Eligibility criteria expanded, about 5 wordsv2
  7. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Percentage of Participants Who Complete Colorectal Cancer Screening Within 6 Months
Timeframe: Up to 6 months

Arms and interventions

Reminder-Only GroupExperimental

Participants in this group will receive a standard screening reminder via mailed letter or, if they have an active patient portal account through the University of Miami health (UHealth) portal. Total participation duration is approximately nine (9) months.

Reminder + Blood-Based Option GroupExperimental

Participants in this group will receive a similar reminder, but with the additional option of completing a blood-based screening test (ShieldTM). Communication will be delivered via mailed letter or the UHealth patient portal. Total participation duration is approximately nine (9) months.

Behavioral: Screening Reminder

Procedures: Blood Sample Collection

Sites

1 site in 1 country

  • University of MiamiMiami, Florida, United States